Miller School’s Strategic Research Planning Session Aims at Creating Synergies for the Future 11.15.2019
Interdisciplinary collaboration, harnessing big data science, the promise of nanotechnology, and community outreach offer new opportunities to advance the University of Miami Miller School of Medicine’s research programs, according to the school’s leaders.
For nearly 10 years, Cherise Irons suffered migraines so intense she sometimes blacked out while driving her car. Ultimately, it affected her ability to continue in her role as assistant principal at a Maryland high school. “It's affecting my sleep. My appetite is gone, I'm starting to feel tingling in my fingers and toes,” she said, recalling a low point in her battle against migraines.
Miller School Performs First-Ever Male Fertility Microsurgery Using Innovative Imaging Tool 11.11.2019
A new imaging tool has the potential to transform microsurgical procedures for many specialties, including male fertility surgery. Ranjith Ramasamy, M.D., director of male reproductive medicine and surgery and assistant professor of urology at the University of Miami Miller School of Medicine, and his team performed the first-ever male infertility microsurgery in Florida using the ORBEYE, a 4K-3D video microscope.
Restorative Practice Program Offers Medical Students Insights on Building an Inclusive Culture 11.07.2019
Tizeta Wolde appreciates the University of Miami Miller School of Medicine’s efforts to support diversity, inclusion and equity. A second-year medical student whose family is from Ethiopia, Wolde is actively involved in the school’s new Restorative Practice Program. “We meet monthly, talk about our experiences and learn from each other,” said Wolde.
Innovative Clinical Trial to Test Stem Cells for Reducing Alcohol Intake and Mood Symptoms 11.07.2019
Along with education and clinical care, the University of Miami Miller School of Medicine Department of Psychiatry & Behavioral Sciences conducts research into a wide range of disorders. “We have a number of ongoing clinical trials into depression, anxiety, addictions, post-traumatic stress disorders and other issues,” said Gabriela Vargas, M.B.A., project manager of the Behavioral Research Assessment Center.
Neuromuscular experts with the University of Miami Health System and the Miller School of Medicine will launch a Phase 1/2 clinical trial (NCT04146051) using the CAR-T drug, Descartes-08, to treat patients with generalized myasthenia gravis.
As if there hadn’t been enough suffering, a fatal car accident occurred recently in Cooper’s Town, a tiny community on Great Abaco Island in the Bahamas, one of the areas pummeled by Hurricane Dorian in early September.
The University of Miami Health System plans to continue the expansion of its services throughout South Florida by building a medical center in Downtown Doral, the 250-acre mixed-use community developed by Codina Partners.
Sylvester Researchers Discover a Possible Pathway for Immune Therapy in Pancreatic Cancer 11.04.2019
Immune therapy has not worked well in pancreatic cancer because of the cancer’s inherent immune resistance. Sylvester Comprehensive Cancer Center scientists have discovered a way to outsmart the deadly cancer’s ability to prevent immune checkpoint inhibitor therapy from killing pancreatic cancer cells.
The biologic drug ustekinumab effectively induced and maintained remission in patients with moderate to severe ulcerative colitis, according to a phase 3 study published in the prestigious New England Journal of Medicine (NEJM).